LSP acquired by EQT and rebranded EQT Life Sciences is one of Europe’s largest and most experienced healthcare investors, targeting innovative life sciences and health care companies.
| Website | https://eqtgroup.com/lifesciences |
| Revenue | $2.3 billion |
| Employees | 104 (70 on RocketReach) |
| Founded | 1987 |
| Industry | Venture Capital and Private Equity Principals |
| Keywords | Healthcare Investment, Life Sciences Investment, Biotechnology Investment, Pharmaceutical Investment, Health Tech Investment, Private Equity Healthcare, Innovative Healthcare, Healthcare Portfolio, Biotech Portfolio, Pharmaceutical Portfolio, Growth Equity Healthcare, Venture Capital Healthcare, Healthcare Acquisitions, Pharmaceutical Acquisitions |
| Competitors | Morgan Stanley, Advent International, New Enterprise Associates (NEA), OrbiMed, RA Capital Management, L.P., Frazier Healthcare Partners, Canaan, SV Health Investors, TPG, HealthQuest Capital +39 more (view full list) |
Looking for a particular LSP employee's phone or email?
The LSP annual revenue was $2.3 billion in 2026.
Malcolm Lai is the Managing Director of LSP.
70 people are employed at LSP.